The Indian aqua inputs and supplements (for shrimps) market size reached INR 34.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach INR 92.1 Billion by 2032, exhibiting a growth rate (CAGR) of 11.3% during 2024-2032.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
INR 34.3 Billion |
Market Forecast in 2032
|
INR 92.1 Billion |
Market Growth Rate 2024-2032 | 11.3% |
Aqua inputs and supplements refer to the chemical substances, including antibiotics, that are utilized for shrimp health management. These substances protect shrimps from vibriosis and other luminescent bacteria, along with preventing any disease outbreak during the farming period. In India, these chemicals are increasingly being used in shrimp aquaculture to ensure a healthy and sustainable environment for shrimp.
Over the years, India has emerged as one of the leading shrimp producers in the world which has given a boost to the aquaculture activities in the country. In addition to this, the rising consumer health consciousness has led to a shift from high-calorie diet to protein-rich seafood, such as shrimps. Owing to this, several manufacturers are introducing improved and effective chemical products targeting shrimp aquaculture. Moreover, India is also one of the low-cost producers of medicines, drugs, and supplements, this has enabled India to become an economical producer of aqua inputs and supplements, thereby proliferating the export activities.
IMARC Group provides an analysis of the key trends in each sub-segment of the Indian aqua inputs and supplements (for shrimps) market report, along with forecasts at the country and state level from 2024-2032. Our report has categorized the market based on end-use and product type.
Breakup by End-Use:
Breakup by Product Type:
Breakup by State:
The competitive landscape of the industry has also been examined with some of the key players being Bayer CropScience Limited, Biostadt India Limited, C. P. Aquaculture (INDIA) Private Limited, Growel Formulations Pvt. Ltd., Gentle Bio-Sciences Pvt. Ltd., Hi-Tech Pharma, Intas Animal Health, Kemin Industries South Asia Pvt. Ltd, Neospark Drugs and Chemicals Private Limited, Poseidon Biotechnology, PVS Group, Srinivasa Cystine Pvt. Ltd., Sanzyme Biologics, SDC Agro-Vet India Pvt. Ltd., DeVee Biologicals Pvt. Ltd., Synergy Biotechnologies, Virbac Animal Health India Private Limited, etc.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | INR Billion |
Segment Coverage | End-Use, Product Type, State |
States Covered | Andhra Pradesh, West Bengal, Odisha, Gujarat |
Companies Covered | Bayer CropScience Limited, Biostadt India Limited, C. P. Aquaculture (INDIA) Private Limited, Growel Formulations Pvt. Ltd., Gentle Bio-Sciences Pvt. Ltd., Hi-Tech Pharma, Intas Animal Health, Kemin Industries South Asia Pvt. Ltd, Neospark Drugs and Chemicals Private Limited, Poseidon Biotechnology, PVS Group, Srinivasa Cystine Pvt. Ltd., Sanzyme Biologics, SDC Agro-Vet India Pvt. Ltd., DeVee Biologicals Pvt. Ltd., Synergy Biotechnologies and Virbac Animal Health India Private Limited |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 2699 Five User License: US$ 3699 Corporate License: US$ 4699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The India aqua inputs and supplements (for shrimps) market was valued at INR 34.3 Billion in 2023.
We expect the India aqua inputs and supplements (for shrimps) market to exhibit a CAGR of 11.3% during 2024-2032.
The rising consumer preference for protein-rich seafood, such as shrimps, along with the in growing adoption of aqua inputs and supplements in shrimp aquaculture to ensure a healthy and sustainable environment for shrimp, is primarily driving the India aqua inputs and supplements (for shrimps) market.
The sudden outbreak of the COVID-19 pandemic had led to the implementation of stringent lockdown regulations across the nation, resulting in the temporary halt of various aquaculture activities for shrimps, thereby negatively impacting the Indian market for aqua inputs and supplements (for shrimps).
Based on the end-use, the India aqua inputs and supplements (for shrimps) market has been segregated into feed and disease management, water management, and soil management. Among these, feed and disease management currently exhibits a clear dominance in the market.
Based on the product type, the India aqua inputs and supplements (for shrimps) market can be bifurcated into probiotics, vitamins and mineral supplement, growth promoter, disinfectant, oxygen enhancer, zeolite, immunostimulant, liming material, organic/inorganic fertilizers, and others. Currently, probiotics hold the largest market share.
On a regional level, the market has been classified into Andhra Pradesh, West Bengal, Odisha, and Gujarat.
Some of the major players in the India aqua inputs and supplements (for shrimps) market include Bayer CropScience Limited, Biostadt India Limited, C. P. Aquaculture (INDIA) Private Limited, Growel Formulations Pvt. Ltd., Gentle Bio-Sciences Pvt. Ltd., Hi-Tech Pharma, Intas Animal Health, Kemin Industries South Asia Pvt. Ltd, Neospark Drugs and Chemicals Private Limited, Poseidon Biotechnology, PVS Group, Srinivasa Cystine Pvt. Ltd., Sanzyme Biologics, SDC Agro-Vet India Pvt. Ltd., DeVee Biologicals Pvt. Ltd., Synergy Biotechnologies, Virbac Animal Health India Private Limited, etc.